Ludwig Enterprises (LUDG) EBITDA Margin (2024)

Ludwig Enterprises (LUDG) posted EBITDA Margin of 2124.22% for Q4 2024, up 101.24% on a QoQ basis from 171275.36% in Q3 2024.

Ludwig Enterprises (LUDG) EBITDA Margin (2024) Analysis & Trends

Ludwig Enterprises' EBITDA Margin history runs 1 years deep, the most recent figure standing at 2124.22% for Q4 2024.

Quarterly EBITDA Margin changed N/A year-over-year to 2124.22% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 598243.78% (changed N/A YoY) and the FY2024 annual result came in at 598243.78%, changed N/A from the prior year.
EBITDA Margin was 2124.22% for Q4 2024 at Ludwig Enterprises, up from 171275.36% in the prior quarter.
Across five years, EBITDA Margin topped out at 2124.22% in Q4 2024 and bottomed at 3655790.0% in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	12.05%
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	15.55%
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	19.10%
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	21.16%
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	28.97%
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	21.42%
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	6.17%
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	10.04%
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Ludwig Enterprises	3.27 Mn	3.27 Mn	-	-

Download Data